Breaking

Police leadership needs fundamental overhaul, review finds Astonished Belgium vow to ‘defend football’ after Fifa’s shock Balogun reversal Queiroz leaves Ghana following World Cup exit Rodríguez defends Venezuela’s emergency earthquake response as number of bodies expected to soar Australia give improved England plenty to ponder one year out from Ashes Jannik Sinner swats aside Mochizuki to reach Wimbledon quarter-finals How Osaka pulled off the upset over Sabalenka -- a... ‘They’ve tried to kill me for 23 years’: Cristiano Ronaldo says this World Cup will be his last Troy keeps season alive, ousts Ole Miss at MCWS Could Farage quit? Questions swirl over Reform UK leader’s future

NEWSREEL

The day, in 30-second reels.

--:--:--

Science / Reel

Science · Video brief

Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

AP News· Apr 18, 2026 · 7:39 PM · 6 views

Trump's new executive order accelerates the review of controversial psychedelic drugs like ibogaine, potentially changing the landscape of mental health treatment. While veterans and lawmakers push for access due to its potential benefits, concerns remain about serious safety risks. How will this impact the future of psychedelic therapies in the U.S.? #Psychedelics #Ibogaine #MentalHealth #TrumpOrder #Veterans

Originally reported by AP News. Read the full story →

0 Comments

No comments yet. Be the first.

Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

More in Science

The Guardian view on gene-edited humans: darker uses must be acknowledged alongside medical ones | Editorial

Bomb the Arctic, dam the Mediterranean and build a second moon: five outlandish plans to remodel our climate

Elon Musk posted twice as often on UK race and immigration as about SpaceX in IPO run-up

0 Comments